Curate Hepatology Models: An Update
210 likes | 389 Vues
Curate Hepatology Models: An Update. Harvey Ho, Hanne Nielsen, Peter Hunter Bioengineering Institute University of Auckland, New Zealand CellML Workshop, Auckland, New Zealand 13 March 2012. Background Why systems biology? International Initiatives Hepatology Model Curation
Curate Hepatology Models: An Update
E N D
Presentation Transcript
Curate Hepatology Models: An Update Harvey Ho, Hanne Nielsen, Peter Hunter Bioengineering Institute University of Auckland, New Zealand CellML Workshop, Auckland, New Zealand 13 March 2012
Background • Why systems biology? • International Initiatives • Hepatology Model Curation • Previous work • Models added • Issues arising • Future Direction - Some personal thoughts • Create cutting-edge models • Clinical connection Outline 2
Why systems biology? Background Image source: SBMC’2012 “The rhythmicity of the heart is not encoded at a subcellular level – so looking for a genetic basis for this behaviour, for example, is futile - but first emerges at the level of the individual cell. It is modulated as the other layers of the system are combined: from an individual cell, the electrophysiology of its encapsulating membrane, up to the tissue level and finally whole organ” - Denis Nobel
Background Systems biology for the liver: • The same methodology applies to the liver • ‘Top-down’ and ‘Bottom-up’ *Abbott, Germans cook up live project, Nature, Vol 468, P879 *Abbott, Germans cook up live project, Nature, Vol 468, P879
Int’l Research HepatoSys project • €36M project, 2004-2009 by the German Federal Ministry of Education and Research (BMBF) • Investigates all processes within the liver, with a focus on hepatocytes
Int’l Research Virtual Liver Network • with funding €42M for 5 years • ~250 scientists in 69 research groups in Germany • Three major areas of focus: • The Liver Cell • Beyond the Cell • Integration and Translation *Abbott, Germans cook up live project, Nature, Vol 468, P879, 2010
Previous work • Papers sourced from HepatoSys publication (Jan 2009) • Total papers: 249 • Keyword ‘Platform Modelling’: 58 • Selection criteria • Equation formation • Parameter completeness • Initial conditions
Previous work amino acid metabolism Acikgoz 2009 Guthke 2006 Drug biotransformation liver regeneration Chauhan 2008 Klamt 2003
Issues Arising • Uncodable Models • Missing Units and Initial Values - have to make guesses -> uncertainty • Errors in Printed Papers • Invalid emails for published author contacts 11
Curate New Models Methods/Strategy • Smaller models first, then larger models • Older models first, then newer models • Connection between models • Model evolution • Collaborators, strategically important
Examples Larsen_2003 • Models of Prof. Ursula Kummer (Dept of Modeling of Biological Processes, Uni of Heidelberg) Grubelnik _2001 Kummer_2000 Marhl_2000 1. Grubelnik et al, ‘Mitochondria regulate the amplitude of simple and complex calcium oscillations’, 2001 Biophysical Chemistry, 94, 59-74. 2. Kummer et al, ‘Switching from Simple to Complex Oscillations in Calcium Signaling’, 2000 Biophysical Journal, 79, 1188-1195
Examples Gall_2009 • Model evolution diagram Gall_2000 Cardenas_1996 Dupont_1992 Goldbeter, Berridge 1. Gall et al, ‘Activation of the Liver Glycogen Phosphorylase by Ca2+ Oscillations: a Theoretical Study‘, 2000, Journal of Theoretical Biology, 207, 445-454 2. Cardenas and Goldbeter, ‘The Glucose-induced Switch Between Glycogen Phosphorylase and Glycogen Synthase in the Liver: Outlines of a Theoretical Approach’, 1996 Journal of Theoretical Biology, 182, 421-426.
Other curated models Swat_2004 mammalian G1/S transition metabolism schmitmeier_2007
Section III: Future Direction Some Personal Thoughts 17
CellML • What we have learned? • Model evolution • Hierarchy • Public, private interface • Understand the underlying physiology • Different components integrated to form a new model • Work with key research groups • User requirement • Proactive curating
Collaboration with transplantation surgeon, interventional radiologists Clinical Connection • Liver resection to treat tumour • Liver transplantation Connect to microscale models Image courtesy of Dr. Adam Bartlett 19
Dedicated to Prof. Andrew Pullan (1963-2012) Clinical connection “The other drug ipilmumab cannot be considered an option at this stage as my liver is too compromised to be able to handle it.”, 14 Jul 2011http://andrewsrecovery.blogspot.co.nz/ • Drug induced liver injury • Hepatotoxity • mitochondrial damage • reactive metabolite effects • … • Toxicity pathways -> safer drugs Circulation model Homeostasis of hepatocytes, inflammatory mediator secretion from Kupffer cells Gene signature for hepatotoxity
Thanks for your attention. Questions? 21